Impact on post liver transplant outcomes of response to treatment with terlipressin and albumin in patients with hepatorenal syndrome

被引：0
|
作者：
Vettore, Elia [1 ]
Piano, Salvatore [1 ]
Tonon, Marta [1 ]
Romano, Antonietta [1 ]
Gambino, Carmine [1 ]
Bertoli, Eleonora [1 ]
Fasolato, Silvano [1 ]
Zanus, Giacomo [2 ]
Boccagni, Patrizia [2 ]
Burra, Patrizia [3 ]
Cillo, Umberto [2 ]
Angeli, Paolo [1 ]
机构：
[1] Univ Padua, Dept Med DIMED, UIMH, Padua, Italy
[2] Dept Surg Oncol & Gastroenterol, Hepatobiliary Surg & Liver Transplantat Unit, Padua, Italy
[3] Gastroenterol Multivisceral Transplant Unit, Padua, Italy
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)31142-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-403
引用
收藏
页码：E572 / E572
页数：1
相关论文
共 50 条
  • [41] Liver Transplant Affects Survival Outcomes in Patients (pts) with Type 1 Hepatorenal Syndrome (HRS) Treated with Terlipressin vs Placebo
    Boyer, Thomas D.
    Rossaro, Lorenzo
    Regenstein, Frederick
    Teuber, Peter
    Garcia-Tsao, Guadalupe
    Sanyal, Arun
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 450 - 450
  • [42] URINARY BIOMARKER NGAL IN PATIENTS WITH HEPATORENAL SYNDROME: ACCURACY STUDY IN PREDICTION OF NO RESPONSE TO THERAPY WITH ALBUMIN AND TERLIPRESSIN
    Ximenes, R. O.
    Helou, C.
    Diniz, M.
    Barbeiro, D.
    Souza, H.
    D'Albuquerque, L. A.
    Carrilho, F.
    Farias, A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S665 - S666
  • [43] Is type 2 hepatorenal syndrome still a potential indication for treatment with terlipressin and albumin?
    Angeli, Paolo
    Piano, Salvatore
    LIVER TRANSPLANTATION, 2015, 21 (11) : 1335 - 1337
  • [44] Role of Terlipressin and Albumin Combination versus Albumin Alone in Hepatorenal Syndrome
    Zafar, Shamail
    Haque, Israr
    Tayyab, Ghias Un
    Khan, Gulsena
    Chaudry, Nusrat
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S175 - S176
  • [45] Randomized, comparative study of terlipressin and albumin vs albumin alone in patients with cirrhosis and hepatorenal syndrome
    Martin-Llahi, M.
    Pepin, M. N.
    Guevara, M.
    Torre, A.
    Monescillo, A.
    Soriano, G.
    Diaz, E.
    Such, J.
    Salmeron, F. J.
    Andreu, H.
    Sola, R.
    Fabrega, E.
    De las Heras, D.
    Rodes, J.
    Arroyo, V.
    Gines, P.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S36 - S36
  • [46] Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?
    Altun, Reskan
    Korkmaz, Murat
    Yildirim, Emre
    Ocal, Serkan
    Akbas, Enver
    Selcuk, Haldun
    SPRINGERPLUS, 2015, 4 : 1 - 6
  • [47] Response to Terlipressin in Hepatorenal Syndrome: Predict to Prognosticate
    Satsangi, Sandeep
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (07) : 1173 - 1173
  • [48] Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome
    Moore, Kevin
    Jamil, Khurram
    Verleger, Katharina
    Luo, Linlin
    Kebede, Nehemiah
    Heisen, Marieke
    Corman, Shelby
    Leonardi, Roberta
    Bakker, Rachel
    Ma, Christine
    Shamseddine, Nisreen
    Huang, Xingyue
    Allegretti, Andrew S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (02) : 351 - 358
  • [49] Low doses of terlipressin and albumin in the type I hepatorenal syndrome
    Pulvirenti, Davide
    Tsami, Aikaterini
    ITALIAN JOURNAL OF MEDICINE, 2008, 2 (03) : 34 - 38
  • [50] Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
    Cavallin, Marta
    Kamath, Patrick S.
    Merli, Manuela
    Fasolato, Silvano
    Toniutto, Pierluigi
    Salerno, Francesco
    Bernardi, Mauro
    Romanelli, Roberto Giulio
    Colletta, Cosimo
    Salinas, Freddy
    Di Giacomo, Antonio
    Ridola, Lorenzo
    Fornasiere, Ezio
    Caraceni, Paolo
    Morando, Filippo
    Piano, Salvatore
    Gatta, Angelo
    Angeli, Paolo
    HEPATOLOGY, 2015, 62 (02) : 567 - 574
12345